| | | | | |
FATE Fate Therapeutics, Inc. | $2,7150 | +12,19% | $244,77M | $8,00M | |
FRD Friedman Industries Inc. Common Stock | $32,1650 | -0,82% | $244,71M | $51,75K | |
SCM STELLUS CAPITAL INVESTMENT CORPORATION | $8,4200 | -1,75% | $244,02M | $196,51K | |
INR Infinity Natural Resources, Inc. | $12,7000 | -0,31% | $243,77M | $249,14K | |
RAAQ Real Asset Acquisition Corp. Class A Ordinary Share | $10,7500 | +0,09% | $243,34M | $185,56K | |
| $13,1100 | +0,15% | $243,33M | $58,92K | |
REFI Chicago Atlantic Real Estate Finance, Inc. Common Stock | $10,7100 | -3,25% | $243,19M | $165,77K | |
| $2,5800 | -0,77% | $242,80M | $735,23K | |
| $14,1000 | +1,66% | $242,53M | $125,06K | |
MMT Aberdeen Multi-Market Income Fund | $4,4000 | -0,45% | $242,20M | $775,14K | |
SUJA Suja Life, Inc. Class A Common Stock | $10,1800 | -4,86% | $241,93M | $210,01K | |
DHY Credit Suisse High Yield Credit Fund | $1,7800 | +1,71% | $241,75M | $754,55K | |
BDSX Biodesix, Inc. Common Stock | $22,1900 | -6,80% | $241,70M | $107,32K | |
ANGI Angi Inc. Class A Common Stock | $5,9500 | +0,85% | $241,47M | $550,41K | |
MCGA Yorkville Acquisition Corp. Class A Ordinary Share | $10,2250 | +0,15% | $240,52M | $117,61K | |
